newsfilter
← Interviews
a16z22 min

Digital Biology with insitro's Daphne Koller

Daphne Koller, Vijay Pande

Fireside Chat, Interview

In-Citro, founded by Coursera co-creator Daphne Koller, is deploying a "data factory" model that uses CRISPR-edited human pluripotent stem cells to systematically generate genetic variance data for drug discovery. The company's proprietary POSH platform and multimodal biology language models analyze hundreds of millions of cells to identify disease mechanisms and predict therapeutic interventions, effectively replacing error-prone murine testing with human-derived systems. Koller aims to deliver a first tranche of medicines to patients by the end of the decade while extending this digital biology framework to address global challenges in agriculture and environmental sustainability.